RNU7-63P

Across TCGA pan-cancer cohorts, RNU7-63P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU7-63P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RNU7-63P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-63P expression acts as an unfavorable survival marker, although some lineages such as SKCM and SARC show a favorable association.

UVM, MESO, and DLBC are the cancer types where RNU7-63P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.104	0.834	<.001	81	view →
MESO	OS	Tertile	III,IV	0.077	0.580	<.001	36	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
LUAD	DFS	Tertile	IV	0.047	0.565	<.001	18	view →
THYM	OS	Tertile	II,III,IV	0.704	0.982	.009	12	view →
UCEC	DFS	Tertile	All	0.646	0.843	.017	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
THCA	DFS	Tertile	All	0.134	0.820	<.001	9	view →
SKCM	DFS	Tertile	All	0.895	0.726	.025	6	view →
KIRP	DFS	Tertile	All	0.687	0.876	.015	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU7-63P–UVM (OS)

Open the UVM breakdown →